Taking treatment to the patient: development of a home TL-01 ultraviolet B phototherapy service

被引:45
作者
Cameron, H [1 ]
Yule, S [1 ]
Moseley, H [1 ]
Dawe, RS [1 ]
Ferguson, J [1 ]
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Dept Dermatol, Photobiol Unit, Dundee DD1 9SY, Scotland
关键词
home phototherapy; narrow-band ultraviolet B; TL-01;
D O I
10.1046/j.1365-2133.2002.04860.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background While most patients requiring phototherapy can attend for hospital-based out-patient ultraviolet (UV) B therapy, a significant number cannot attend because of geographical, work, economic and other reasons. Objectives To determine whether there was a need for home phototherapy in the Tayside area and, if so, to establish protocols and then to assess if such a service would be workable. Methods Patients referred from dermatology out-patient clinics in Tayside for narrow-band UVB (TL-01) phototherapy completed a pilot questionnaire that was followed by a two-phase project. In phase 1, patients with psoriasis were trained to use the home phototherapy equipment (HoPE) within the hospital department under nursing supervision while a teaching package and protocols were developed. In phase 2, home phototherapy was made available for patient use in the community, supported by a specialist home phototherapy nurse. Waldmann UV100 home therapy units were used, with accurate dosimetry. Detailed treatment records were kept and questionnaires were used to assess acceptability and costs of therapy. Results Fifty-two pilot questionnaires were completed. Forty-two per cent of respondents found hospital phototherapy inconvenient and 75% felt phototherapy at home would be helpful. In phase 1, seven of 10 patients trained to use the HoPE completed therapy with the HoPE unit alone, reaching minimal residual activity (MRA) or clearance in a median of 18 exposures (median dose 10.38 J cm(-2)). In phase 2, 32 courses of home phototherapy were given to 30 patients. Of 23 with psoriasis, 18 reached clearance or MRA in a median of 22.5 exposures (median dose 9.84 J cm(-2)). Although self-reported erythema rates appeared higher than expected, all post-treatment questionnaire respondents would choose home phototherapy over hospital therapy if required in the future. Conclusions UVB (TL-01) home phototherapy is a useful practical development that has fulfilled a need in our catchment area. Where appropriate training and support teams are available it appears to be similar in effectiveness to hospital therapy, to be safe and to be cost-effective for patients.
引用
收藏
页码:957 / 965
页数:9
相关论文
共 15 条
[1]  
ABEL EA, 1985, CUTIS, V35, P127
[2]   A COMPARISON OF NARROW-BAND PHOTOTHERAPY (TL-01) AND PHOTOCHEMOTHERAPY (PUVA) IN THE MANAGEMENT OF POLYMORPHIC LIGHT ERUPTION [J].
BILSLAND, D ;
GEORGE, SA ;
GIBBS, NK ;
AITCHISON, T ;
JOHNSON, BE ;
FERGUSON, J .
BRITISH JOURNAL OF DERMATOLOGY, 1993, 129 (06) :708-712
[3]   Narrowband TL-01 phototherapy for patch-stage mycosis fungoides [J].
Clark, C ;
Dawe, RS ;
Evans, AT ;
Lowe, G ;
Ferguson, J .
ARCHIVES OF DERMATOLOGY, 2000, 136 (06) :748-752
[4]  
DEGRUIJL FR, 1996, FUNDAMENTAL BASES PH, P153
[5]   Half-side comparison study on the efficacy of 8-methoxypsoralen bath-PUVA versus narrow-band ultraviolet B phototherapy in patients with severe chronic atopic dermatitis [J].
Der-Petrossian, M ;
Seeber, A ;
Hönigsmann, H ;
Tanew, A .
BRITISH JOURNAL OF DERMATOLOGY, 2000, 142 (01) :39-43
[6]  
Feldman SR, 1996, CUTIS, V58, P71
[7]   NARROW-BAND (TL-01) UVB AIR-CONDITIONED PHOTOTHERAPY FOR CHRONIC SEVERE ADULT ATOPIC-DERMATITIS [J].
GEORGE, SA ;
BILSLAND, DJ ;
JOHNSON, BE ;
FERGUSON, J .
BRITISH JOURNAL OF DERMATOLOGY, 1993, 128 (01) :49-56
[8]   LONG-TERM MODIFIED GOECKERMAN REGIMEN FOR PSORIASIS USING AN ULTRAVIOLET-B LIGHT-SOURCE IN THE HOME [J].
JORDAN, WP ;
CLARKE, AM ;
HALE, RK .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1981, 4 (05) :584-591
[9]   HOME SOLARIUM TREATMENT OF PSORIASIS [J].
LARKO, O ;
SWANBECK, G .
BRITISH JOURNAL OF DERMATOLOGY, 1979, 101 (01) :13-16
[10]  
LOWE NJ, 1992, SEMIN DERMATOL, V11, P284